Metabolic dysfunction-associated steatotic liver disease and urinary system cancers: Mere coincidence or reason for concern?
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a systemic disease characterized by insulin resistance and lipotoxicity. Its association with type 2 diabetes, cardiovascular disease, liver cirrhosis, and hepatocellular carcinoma are well de... ...
